AMBALAL SARABHAI ENTERPRISES
Back to Cashflow Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-2.95 Cr | ₹9.09 Cr | ₹-19 Cr | ₹-5.84 Cr | ₹-14 Cr |
What is the latest Cash Flow from Financing Activities ratio of AMBALAL SARABHAI ENTERPRISES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-2.95 Cr |
Mar2023 | ₹9.09 Cr |
Mar2022 | ₹-19 Cr |
Mar2021 | ₹-5.84 Cr |
Mar2020 | ₹-14 Cr |
How is Cash Flow from Financing Activities of AMBALAL SARABHAI ENTERPRISES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-2.95 Cr | Negative | |
Mar2023 | ₹9.09 Cr | Positive | |
Mar2022 | ₹-19 Cr | Negative | |
Mar2021 | ₹-5.84 Cr | Negative | |
Mar2020 | ₹-14 Cr | - |
Compare Cash Flow from Financing Activities of peers of AMBALAL SARABHAI ENTERPRISES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AMBALAL SARABHAI ENTERPRISES | ₹394.9 Cr | 4.7% | -6.2% | -20% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,084.0 Cr | -0% | -4.6% | 18.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,384.0 Cr | 8.8% | 5.1% | 64.4% | Stock Analytics | |
CIPLA | ₹118,853.0 Cr | 2.4% | -1.1% | 0.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,143.0 Cr | 2.6% | -9.9% | -0.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,459.0 Cr | 3.6% | -0.1% | 22.7% | Stock Analytics |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AMBALAL SARABHAI ENTERPRISES | 4.7% |
-6.2% |
-20% |
SENSEX | 0.7% |
-0.1% |
8.8% |
You may also like the below Video Courses